|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CDH1-TRHDE (FusionGDB2 ID:HG999TG29953) |
Fusion Gene Summary for CDH1-TRHDE |
Fusion gene summary |
Fusion gene information | Fusion gene name: CDH1-TRHDE | Fusion gene ID: hg999tg29953 | Hgene | Tgene | Gene symbol | CDH1 | TRHDE | Gene ID | 999 | 29953 |
Gene name | cadherin 1 | thyrotropin releasing hormone degrading enzyme | |
Synonyms | Arc-1|BCDS1|CD324|CDHE|ECAD|LCAM|UVO | PAP-II|PGPEP2|TRH-DE | |
Cytomap | ('CDH1')('TRHDE') 16q22.1 | 12q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | cadherin-1CAM 120/80E-cadherin 1cadherin 1, E-cadherin (epithelial)cadherin 1, type 1, E-cadherin (epithelial)calcium-dependent adhesion protein, epithelialcell-CAM 120/80epididymis secretory sperm binding proteinepithelial cadherinuvomorulin | thyrotropin-releasing hormone-degrading ectoenzymeTRH-degrading ectoenzymeTRH-specific aminopeptidasepyroglutamyl aminopeptidase IIpyroglutamyl-peptidase IIthyroliberinase | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000562836, ENST00000261769, ENST00000422392, | ||
Fusion gene scores | * DoF score | 21 X 16 X 8=2688 | 19 X 12 X 7=1596 |
# samples | 29 | 21 | |
** MAII score | log2(29/2688*10)=-3.21240833276383 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/1596*10)=-2.92599941855622 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CDH1 [Title/Abstract] AND TRHDE [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CDH1(68835796)-TRHDE(72771775), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | CDH1-TRHDE seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CDH1-TRHDE seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CDH1-TRHDE seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CDH1-TRHDE seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CDH1 | GO:0042307 | positive regulation of protein import into nucleus | 16338932 |
Hgene | CDH1 | GO:0045893 | positive regulation of transcription, DNA-templated | 16338932 |
Hgene | CDH1 | GO:0071285 | cellular response to lithium ion | 12937339 |
Hgene | CDH1 | GO:0071681 | cellular response to indole-3-methanol | 10868478 |
Hgene | CDH1 | GO:0072659 | protein localization to plasma membrane | 17620337 |
Hgene | CDH1 | GO:0098609 | cell-cell adhesion | 16338932|18593713 |
Fusion gene breakpoints across CDH1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across TRHDE (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-VP-A879-01A | CDH1 | chr16 | 68835796 | - | TRHDE | chr12 | 72771775 | + |
ChimerDB4 | PRAD | TCGA-VP-A879-01A | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
ChimerDB4 | PRAD | TCGA-VP-A879 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + |
ChimerDB4 | PRAD | TCGA-VP-A879 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
Top |
Fusion Gene ORF analysis for CDH1-TRHDE |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000562836 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
3UTR-3CDS | ENST00000562836 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + |
3UTR-intron | ENST00000562836 | ENST00000549138 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
3UTR-intron | ENST00000562836 | ENST00000549138 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + |
5CDS-intron | ENST00000261769 | ENST00000549138 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
5CDS-intron | ENST00000261769 | ENST00000549138 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + |
5CDS-intron | ENST00000422392 | ENST00000549138 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
5CDS-intron | ENST00000422392 | ENST00000549138 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + |
In-frame | ENST00000261769 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
In-frame | ENST00000261769 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + |
In-frame | ENST00000422392 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + |
In-frame | ENST00000422392 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000261769 | CDH1 | chr16 | 68835796 | + | ENST00000261180 | TRHDE | chr12 | 72771775 | + | 5047 | 578 | 41 | 2599 | 852 |
ENST00000422392 | CDH1 | chr16 | 68835796 | + | ENST00000261180 | TRHDE | chr12 | 72771775 | + | 4920 | 451 | 64 | 2472 | 802 |
ENST00000261769 | CDH1 | chr16 | 68835796 | + | ENST00000261180 | TRHDE | chr12 | 72771774 | + | 5047 | 578 | 41 | 2599 | 852 |
ENST00000422392 | CDH1 | chr16 | 68835796 | + | ENST00000261180 | TRHDE | chr12 | 72771774 | + | 4920 | 451 | 64 | 2472 | 802 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000261769 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + | 3.44E-05 | 0.99996555 |
ENST00000422392 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771775 | + | 3.16E-05 | 0.9999684 |
ENST00000261769 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + | 3.44E-05 | 0.99996555 |
ENST00000422392 | ENST00000261180 | CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + | 3.16E-05 | 0.9999684 |
Top |
Fusion Genomic Features for CDH1-TRHDE |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + | 0.001855193 | 0.99814487 |
CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + | 0.001855193 | 0.99814487 |
CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + | 0.001855193 | 0.99814487 |
CDH1 | chr16 | 68835796 | + | TRHDE | chr12 | 72771774 | + | 0.001855193 | 0.99814487 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CDH1-TRHDE |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:68835796/chr12:72771775) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | TRHDE | chr16:68835796 | chr12:72771774 | ENST00000261180 | 1 | 19 | 404_408 | 351 | 1025.0 | Region | Substrate binding | |
Tgene | TRHDE | chr16:68835796 | chr12:72771775 | ENST00000261180 | 1 | 19 | 404_408 | 351 | 1025.0 | Region | Substrate binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 838_851 | 129 | 883.0 | Compositional bias | Note=Ser-rich |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 838_851 | 129 | 883.0 | Compositional bias | Note=Ser-rich |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 155_262 | 129 | 883.0 | Domain | Cadherin 1 |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 263_375 | 129 | 883.0 | Domain | Cadherin 2 |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 376_486 | 129 | 883.0 | Domain | Cadherin 3 |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 487_593 | 129 | 883.0 | Domain | Cadherin 4 |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 594_697 | 129 | 883.0 | Domain | Cadherin 5 |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 155_262 | 129 | 883.0 | Domain | Cadherin 1 |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 263_375 | 129 | 883.0 | Domain | Cadherin 2 |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 376_486 | 129 | 883.0 | Domain | Cadherin 3 |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 487_593 | 129 | 883.0 | Domain | Cadherin 4 |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 594_697 | 129 | 883.0 | Domain | Cadherin 5 |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 758_769 | 129 | 883.0 | Region | Note=Required for binding CTNND1 and PSEN1 |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 811_882 | 129 | 883.0 | Region | Note=Required for binding alpha%2C beta and gamma catenins |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 758_769 | 129 | 883.0 | Region | Note=Required for binding CTNND1 and PSEN1 |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 811_882 | 129 | 883.0 | Region | Note=Required for binding alpha%2C beta and gamma catenins |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 155_709 | 129 | 883.0 | Topological domain | Extracellular |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 731_882 | 129 | 883.0 | Topological domain | Cytoplasmic |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 155_709 | 129 | 883.0 | Topological domain | Extracellular |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 731_882 | 129 | 883.0 | Topological domain | Cytoplasmic |
Hgene | CDH1 | chr16:68835796 | chr12:72771774 | ENST00000261769 | + | 3 | 16 | 710_730 | 129 | 883.0 | Transmembrane | Helical |
Hgene | CDH1 | chr16:68835796 | chr12:72771775 | ENST00000261769 | + | 3 | 16 | 710_730 | 129 | 883.0 | Transmembrane | Helical |
Tgene | TRHDE | chr16:68835796 | chr12:72771774 | ENST00000261180 | 1 | 19 | 1_40 | 351 | 1025.0 | Topological domain | Cytoplasmic | |
Tgene | TRHDE | chr16:68835796 | chr12:72771774 | ENST00000261180 | 1 | 19 | 62_1024 | 351 | 1025.0 | Topological domain | Extracellular | |
Tgene | TRHDE | chr16:68835796 | chr12:72771775 | ENST00000261180 | 1 | 19 | 1_40 | 351 | 1025.0 | Topological domain | Cytoplasmic | |
Tgene | TRHDE | chr16:68835796 | chr12:72771775 | ENST00000261180 | 1 | 19 | 62_1024 | 351 | 1025.0 | Topological domain | Extracellular | |
Tgene | TRHDE | chr16:68835796 | chr12:72771774 | ENST00000261180 | 1 | 19 | 41_61 | 351 | 1025.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein | |
Tgene | TRHDE | chr16:68835796 | chr12:72771775 | ENST00000261180 | 1 | 19 | 41_61 | 351 | 1025.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Top |
Fusion Gene Sequence for CDH1-TRHDE |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>15044_15044_1_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000261769_TRHDE_chr12_72771774_ENST00000261180_length(transcript)=5047nt_BP=578nt AGCCAATCAGCGGTACGGGGGGCGGTGCCTCCGGGGCTCACCTGGCTGCAGCCACGCACCCCCTCTCAGTGGCGTCGGAACTGCAAAGCA CCTGTGAGCTTGCGGAAGTCAGTTCAGACTCCAGCCCGCTCCAGCCCGGCCCGACCCGACCGCACCCGGCGCCTGCCCTCGCTCGGCGTC CCCGGCCAGCCATGGGCCCTTGGAGCCGCAGCCTCTCGGCGCTGCTGCTGCTGCTGCAGGTCTCCTCTTGGCTCTGCCAGGAGCCGGAGC CCTGCCACCCTGGCTTTGACGCCGAGAGCTACACGTTCACGGTGCCCCGGCGCCACCTGGAGAGAGGCCGCGTCCTGGGCAGAGTGAATT TTGAAGATTGCACCGGTCGACAAAGGACAGCCTATTTTTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGATTACAGTCAAAA GGCCTCTACGGTTTCATAACCCACAGATCCATTTCTTGGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCAAAGTCACGCTGA ATACAGTGGGGCACCACCACCGCCCCCCGCCCCATCAGGTACGATTATATGCAAGACCTGATGCTATCAGAAGAGGATCCGGGGACTATG CTCTCCATATAACAAAGAGATTAATAGAATTTTATGAAGACTACTTTAAAGTGCCCTATTCCTTGCCAAAACTAGATCTTTTAGCTGTGC CTAAGCATCCGTATGCTGCTATGGAGAACTGGGGACTAAGTATTTTTGTGGAACAAAGAATACTGCTGGATCCCAGTGTTTCATCTATTT CTTATTTGCTGGATGTCACCATGGTCATTGTTCATGAGATATGTCACCAGTGGTTTGGTGACCTTGTGACGCCTGTGTGGTGGGAAGACG TGTGGCTGAAGGAAGGGTTTGCTCACTACTTTGAATTTGTTGGTACAGACTACCTCTATCCTGGCTGGAACATGGAAAAGCAGAGGTTTC TGACCGATGTTCTGCATGAAGTGATGCTGCTGGACGGTTTGGCCAGTTCCCATCCAGTATCACAGGAAGTGCTGCAGGCAACAGATATTG ACAGGGTGTTTGACTGGATCGCATATAAAAAGGGTGCTGCTTTAATAAGAATGCTGGCTAATTTTATGGGCCATTCAGTTTTCCAGAGGG GTTTGCAAGATTATTTAACCATTCATAAGTATGGTAATGCAGCCAGAAATGATCTCTGGAATACATTATCGGAGGCTTTAAAAAGAAATG GGAAATATGTAAATATACAAGAAGTAATGGATCAGTGGACACTCCAGATGGGTTATCCTGTTATCACCATCTTGGGAAACACAACAGCAG AAAATAGAATAATAATTACCCAACAGCATTTTATCTATGATATCAGTGCTAAAACTAAAGCACTTAAACTTCAGAATAACAGTTACCTGT GGCAGATTCCATTAACTATTGTGGTAGGAAATAGAAGCCATGTGTCTTCAGAAGCAATTATTTGGGTGTCTAACAAATCAGAGCACCACA GAATAACTTATTTGGACAAAGGAAGCTGGCTGCTGGGGAACATCAATCAAACTGGCTATTTTAGAGTCAACTATGACCTAAGGAACTGGA GATTATTAATTGATCAATTAATCCGGAATCATGAGGTTCTTTCTGTCAGTAACCGAGCGGGCTTGATCGATGATGCCTTCAGCCTAGCCA GGGCTGGCTATTTGCCTCAGAATATTCCTCTGGAGATTATCAGATACCTGTCTGAGGAGAAGGATTTTCTTCCTTGGCATGCTGCCAGCC GAGCTCTTTATCCTCTAGATAAATTACTGGACCGCATGGAAAACTACAACATTTTCAATGAATATATTTTAAAGCAAGTTGCAACAACAT ATATCAAGCTTGGGTGGCCGAAAAATAATTTTAATGGATCTCTTGTTCAAGCATCCTACCAACATGAAGAACTACGTAGAGAAGTTATAA TGCTGGCCTGCAGTTTTGGCAACAAGCACTGTCACCAACAGGCATCAACACTTATTTCAGATTGGATTTCCAGCAACAGGAACAGAATAC CACTAAATGTTAGAGACATCGTATACTGTACAGGAGTGTCACTACTGGATGAGGATGTCTGGGAATTCATATGGATGAAATTCCATTCCA CCACAGCAGTTTCTGAGAAGAAAATATTATTGGAAGCCTTAACTTGCAGTGATGACAGGAATTTATTAAACAGGCTTCTAAATCTGTCAC TGAATTCTGAGGTGGTGCTGGATCAAGATGCAATTGATGTCATAATCCATGTAGCTCGAAATCCACATGGTCGAGACCTTGCCTGGAAGT TTTTCAGGGATAAATGGAAGATATTAAATACCAGGTATGGAGAAGCATTGTTTATGAATTCCAAACTCATCAGTGGTGTCACAGAATTTC TTAATACTGAAGGTGAACTCAAAGAGCTCAAGAACTTCATGAAAAACTATGATGGGGTAGCTGCTGCTTCTTTCTCACGAGCTGTGGAAA CTGTCGAAGCCAATGTGCGCTGGAAAATGCTTTACCAAGACGAGCTTTTCCAATGGTTAGGAAAAGCTCTAAGACACTAATATATGTATC TTATAAACAAACAATTCAACTCAGAAGTTTATGAGAAGACACGCTTTTTGTGGAATGAGGAAAATGTACTACCTAGAAAATGGCCAGATT TTCAGTGTTAACGTGTGGGAGGAATTTTTTTTTTAGTTTTTATTTTTTGGTTTTGGGGGATATTTTTTATTTGTTTCATTCATTCTGTTC TGTTTCTCTACTGGGTGTTCCTCTCTAAAGAAACTCTTGCAAGTGAAACTAGCCATGATTGCTTCAGCTGTACATTCCTTGCTGTACAGG ACCAAATATGATAGTGATGCATGTTGATGTTACAGTCAATTTGGAAAAACATATTCAGAATATCTGTGCATGGATATATTGTCCTGCCTG TGTTCCAGCATGCTTATTTCAAACGTCCAGTGTTGTGTGTGAATATGTGTTACACCTAGGATGGGCATTATGCAAAAGCACAAAGATTAT ATATGACAATCAGTATTGCAATGAAAGAAAAACTAAAAACAGAAATGATATTCTCAATTTTGGGCAATGTGAGAGGTAAAATAGCCCTTG ACATGATGAACATCACTTATTTCAGCACTTGGATTGTCTGGCAATGATTACTGTGTTGCTAACTCATTTTCTTTGAGTTAAAGCTGTGTA TACATTTTAAAAGGCATATAGATAGTGTATGCATATGTATATGTACATAGGGAAGCCCCATATGTATATAGTATGTTGTACACTGCACAT GTACAAAGAATGTCTTCAGATCAAAGAAAATTTATCTCTTTTTATAAACTTAAGGACAGTTGCAAAAGGCTTCAAGGAATTTATCTCAAC ATTATTCTTTCTATGTCCTAACTAAATTTCTCAACTGTTATGAATTTTTCATCTACTTCTTGAACAGTGGTCTATTCTGCTACATGAAGA TGAATACAAACAAAATTTTTGTATAAACTACTATTCCAGTTCTCCTGTGTCAGTCTTGCCTATAGATTTTGCCATCGTTTTCTGTCAAAG TTCCTTTTGCATGAAACAATTATGCAAACTTATAATTATTAGTGCTGAAAAAGAGTTTATTTTCCATCTTGTTTGTTTTCCTACCTTATG CTGAGTAGTCCAGAGAGTTAAAAAAATTCTCTGCATGTTGGTCTTTTAAGTCTGTTTTGCTCTAATCCTCCATTAAGCGAGCATACCTCA AGTGGGTCTATTAGCATTTAATGACCTTTTGTGCCAGTTGTGCCATCCCTTAAGATGAAAAGTTCCTTTTCTTGTGTTAATGTACAAAGC TTTTCTTTTGGCACTGACAACTGTGTTCTACCTGGGAATTTTGAATAGCCATTTTCATGGCTGTGTGTTGTGTAACACAAATGTTTTTAA ATGGTATTCTCACCCAGTAGGCCAGCTCTCCAAACGTTGCTTAGATGCTTCAAAATTAGCATATTTTAAGTTTACCAGTATAAAATACCA ATGCAACTACTCTACATAGCCAAATGTTTGTAAATCACGTCTTATTTTCCTGAGGTTTTTCACTCCACCAAATCTTACAAATCATTGAAA GAAATATATTCTAACAGTACGCACTGAATAGTGAAAATAATTAGACATTTTAAGAACCAGAGCCATAGAATTATTTTAAATTAGTAGAAA AGAGGAGCTATTTCCGAATCTATAGAATAAAGTACCACCTAAAACTGAATTTTATCATATAAGCAAGTAATACCTATTAGTCATACCTAA ATTTTTCAGCACTTCATTCAATTAAAATACATGAATTTTAAATATTTTACATGATGTGAATAGGCATGATAATACTTTTAGTATAAAATC TAAACTTTTTCCATTTATCAGAAATGATAAAATCCAGTTACCACATATCACGTTTATAAAATCCTTAATTAAATGAGTAACTTCTAAAAT ATAACAATACTAAATATCACACTGCGATGGAGGTCCCAAATATGTGGTCTATCACCACTGAATTCATGTAATAGATAAGAAAAAAATTAG AGGTGGATGTCTTGTTTTGTGTCATGAATTACTAAAATCTCTTAGTAGTTGTGGTATATTTTTGAGTAAAATTACCATTTCCAGATTTGA GTTTGAAGGGCTTTTATAGTTGTATTTTCCTCCTCACTGTTAATAATCATAATCCTTTTTCAGTATTTTAGTGGCCTTGAACAACTGGTT TATCTACAATCTCAAATCCTAAGTGTATAATTATGTGCAATGTTCAATACCTCATATAATACTTGCTCAACAGTATAGTGGTACCAATGG CATTAAGATGGTGTTTTTGTTCTACATATTTTTCAATAATTTATTCTTTCTAATGTTGAAATTATATCAGGCTTTACCGGTTTTTTTAGT TGTTTAAATAAGTAATATTTTCAAAAGAATAAAATAACCAATGATATCTCTTGGAATAATCTGTAAAACGTAGTTATAAAATTCTATTTT >15044_15044_1_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000261769_TRHDE_chr12_72771774_ENST00000261180_length(amino acids)=852AA_BP=179 MAAATHPLSVASELQSTCELAEVSSDSSPLQPGPTRPHPAPALARRPRPAMGPWSRSLSALLLLLQVSSWLCQEPEPCHPGFDAESYTFT VPRRHLERGRVLGRVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVYAWDSTYRKFSTKVTLNTVGHHHRPPPHQV RLYARPDAIRRGSGDYALHITKRLIEFYEDYFKVPYSLPKLDLLAVPKHPYAAMENWGLSIFVEQRILLDPSVSSISYLLDVTMVIVHEI CHQWFGDLVTPVWWEDVWLKEGFAHYFEFVGTDYLYPGWNMEKQRFLTDVLHEVMLLDGLASSHPVSQEVLQATDIDRVFDWIAYKKGAA LIRMLANFMGHSVFQRGLQDYLTIHKYGNAARNDLWNTLSEALKRNGKYVNIQEVMDQWTLQMGYPVITILGNTTAENRIIITQQHFIYD ISAKTKALKLQNNSYLWQIPLTIVVGNRSHVSSEAIIWVSNKSEHHRITYLDKGSWLLGNINQTGYFRVNYDLRNWRLLIDQLIRNHEVL SVSNRAGLIDDAFSLARAGYLPQNIPLEIIRYLSEEKDFLPWHAASRALYPLDKLLDRMENYNIFNEYILKQVATTYIKLGWPKNNFNGS LVQASYQHEELRREVIMLACSFGNKHCHQQASTLISDWISSNRNRIPLNVRDIVYCTGVSLLDEDVWEFIWMKFHSTTAVSEKKILLEAL TCSDDRNLLNRLLNLSLNSEVVLDQDAIDVIIHVARNPHGRDLAWKFFRDKWKILNTRYGEALFMNSKLISGVTEFLNTEGELKELKNFM -------------------------------------------------------------- >15044_15044_2_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000261769_TRHDE_chr12_72771775_ENST00000261180_length(transcript)=5047nt_BP=578nt AGCCAATCAGCGGTACGGGGGGCGGTGCCTCCGGGGCTCACCTGGCTGCAGCCACGCACCCCCTCTCAGTGGCGTCGGAACTGCAAAGCA CCTGTGAGCTTGCGGAAGTCAGTTCAGACTCCAGCCCGCTCCAGCCCGGCCCGACCCGACCGCACCCGGCGCCTGCCCTCGCTCGGCGTC CCCGGCCAGCCATGGGCCCTTGGAGCCGCAGCCTCTCGGCGCTGCTGCTGCTGCTGCAGGTCTCCTCTTGGCTCTGCCAGGAGCCGGAGC CCTGCCACCCTGGCTTTGACGCCGAGAGCTACACGTTCACGGTGCCCCGGCGCCACCTGGAGAGAGGCCGCGTCCTGGGCAGAGTGAATT TTGAAGATTGCACCGGTCGACAAAGGACAGCCTATTTTTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGATTACAGTCAAAA GGCCTCTACGGTTTCATAACCCACAGATCCATTTCTTGGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCAAAGTCACGCTGA ATACAGTGGGGCACCACCACCGCCCCCCGCCCCATCAGGTACGATTATATGCAAGACCTGATGCTATCAGAAGAGGATCCGGGGACTATG CTCTCCATATAACAAAGAGATTAATAGAATTTTATGAAGACTACTTTAAAGTGCCCTATTCCTTGCCAAAACTAGATCTTTTAGCTGTGC CTAAGCATCCGTATGCTGCTATGGAGAACTGGGGACTAAGTATTTTTGTGGAACAAAGAATACTGCTGGATCCCAGTGTTTCATCTATTT CTTATTTGCTGGATGTCACCATGGTCATTGTTCATGAGATATGTCACCAGTGGTTTGGTGACCTTGTGACGCCTGTGTGGTGGGAAGACG TGTGGCTGAAGGAAGGGTTTGCTCACTACTTTGAATTTGTTGGTACAGACTACCTCTATCCTGGCTGGAACATGGAAAAGCAGAGGTTTC TGACCGATGTTCTGCATGAAGTGATGCTGCTGGACGGTTTGGCCAGTTCCCATCCAGTATCACAGGAAGTGCTGCAGGCAACAGATATTG ACAGGGTGTTTGACTGGATCGCATATAAAAAGGGTGCTGCTTTAATAAGAATGCTGGCTAATTTTATGGGCCATTCAGTTTTCCAGAGGG GTTTGCAAGATTATTTAACCATTCATAAGTATGGTAATGCAGCCAGAAATGATCTCTGGAATACATTATCGGAGGCTTTAAAAAGAAATG GGAAATATGTAAATATACAAGAAGTAATGGATCAGTGGACACTCCAGATGGGTTATCCTGTTATCACCATCTTGGGAAACACAACAGCAG AAAATAGAATAATAATTACCCAACAGCATTTTATCTATGATATCAGTGCTAAAACTAAAGCACTTAAACTTCAGAATAACAGTTACCTGT GGCAGATTCCATTAACTATTGTGGTAGGAAATAGAAGCCATGTGTCTTCAGAAGCAATTATTTGGGTGTCTAACAAATCAGAGCACCACA GAATAACTTATTTGGACAAAGGAAGCTGGCTGCTGGGGAACATCAATCAAACTGGCTATTTTAGAGTCAACTATGACCTAAGGAACTGGA GATTATTAATTGATCAATTAATCCGGAATCATGAGGTTCTTTCTGTCAGTAACCGAGCGGGCTTGATCGATGATGCCTTCAGCCTAGCCA GGGCTGGCTATTTGCCTCAGAATATTCCTCTGGAGATTATCAGATACCTGTCTGAGGAGAAGGATTTTCTTCCTTGGCATGCTGCCAGCC GAGCTCTTTATCCTCTAGATAAATTACTGGACCGCATGGAAAACTACAACATTTTCAATGAATATATTTTAAAGCAAGTTGCAACAACAT ATATCAAGCTTGGGTGGCCGAAAAATAATTTTAATGGATCTCTTGTTCAAGCATCCTACCAACATGAAGAACTACGTAGAGAAGTTATAA TGCTGGCCTGCAGTTTTGGCAACAAGCACTGTCACCAACAGGCATCAACACTTATTTCAGATTGGATTTCCAGCAACAGGAACAGAATAC CACTAAATGTTAGAGACATCGTATACTGTACAGGAGTGTCACTACTGGATGAGGATGTCTGGGAATTCATATGGATGAAATTCCATTCCA CCACAGCAGTTTCTGAGAAGAAAATATTATTGGAAGCCTTAACTTGCAGTGATGACAGGAATTTATTAAACAGGCTTCTAAATCTGTCAC TGAATTCTGAGGTGGTGCTGGATCAAGATGCAATTGATGTCATAATCCATGTAGCTCGAAATCCACATGGTCGAGACCTTGCCTGGAAGT TTTTCAGGGATAAATGGAAGATATTAAATACCAGGTATGGAGAAGCATTGTTTATGAATTCCAAACTCATCAGTGGTGTCACAGAATTTC TTAATACTGAAGGTGAACTCAAAGAGCTCAAGAACTTCATGAAAAACTATGATGGGGTAGCTGCTGCTTCTTTCTCACGAGCTGTGGAAA CTGTCGAAGCCAATGTGCGCTGGAAAATGCTTTACCAAGACGAGCTTTTCCAATGGTTAGGAAAAGCTCTAAGACACTAATATATGTATC TTATAAACAAACAATTCAACTCAGAAGTTTATGAGAAGACACGCTTTTTGTGGAATGAGGAAAATGTACTACCTAGAAAATGGCCAGATT TTCAGTGTTAACGTGTGGGAGGAATTTTTTTTTTAGTTTTTATTTTTTGGTTTTGGGGGATATTTTTTATTTGTTTCATTCATTCTGTTC TGTTTCTCTACTGGGTGTTCCTCTCTAAAGAAACTCTTGCAAGTGAAACTAGCCATGATTGCTTCAGCTGTACATTCCTTGCTGTACAGG ACCAAATATGATAGTGATGCATGTTGATGTTACAGTCAATTTGGAAAAACATATTCAGAATATCTGTGCATGGATATATTGTCCTGCCTG TGTTCCAGCATGCTTATTTCAAACGTCCAGTGTTGTGTGTGAATATGTGTTACACCTAGGATGGGCATTATGCAAAAGCACAAAGATTAT ATATGACAATCAGTATTGCAATGAAAGAAAAACTAAAAACAGAAATGATATTCTCAATTTTGGGCAATGTGAGAGGTAAAATAGCCCTTG ACATGATGAACATCACTTATTTCAGCACTTGGATTGTCTGGCAATGATTACTGTGTTGCTAACTCATTTTCTTTGAGTTAAAGCTGTGTA TACATTTTAAAAGGCATATAGATAGTGTATGCATATGTATATGTACATAGGGAAGCCCCATATGTATATAGTATGTTGTACACTGCACAT GTACAAAGAATGTCTTCAGATCAAAGAAAATTTATCTCTTTTTATAAACTTAAGGACAGTTGCAAAAGGCTTCAAGGAATTTATCTCAAC ATTATTCTTTCTATGTCCTAACTAAATTTCTCAACTGTTATGAATTTTTCATCTACTTCTTGAACAGTGGTCTATTCTGCTACATGAAGA TGAATACAAACAAAATTTTTGTATAAACTACTATTCCAGTTCTCCTGTGTCAGTCTTGCCTATAGATTTTGCCATCGTTTTCTGTCAAAG TTCCTTTTGCATGAAACAATTATGCAAACTTATAATTATTAGTGCTGAAAAAGAGTTTATTTTCCATCTTGTTTGTTTTCCTACCTTATG CTGAGTAGTCCAGAGAGTTAAAAAAATTCTCTGCATGTTGGTCTTTTAAGTCTGTTTTGCTCTAATCCTCCATTAAGCGAGCATACCTCA AGTGGGTCTATTAGCATTTAATGACCTTTTGTGCCAGTTGTGCCATCCCTTAAGATGAAAAGTTCCTTTTCTTGTGTTAATGTACAAAGC TTTTCTTTTGGCACTGACAACTGTGTTCTACCTGGGAATTTTGAATAGCCATTTTCATGGCTGTGTGTTGTGTAACACAAATGTTTTTAA ATGGTATTCTCACCCAGTAGGCCAGCTCTCCAAACGTTGCTTAGATGCTTCAAAATTAGCATATTTTAAGTTTACCAGTATAAAATACCA ATGCAACTACTCTACATAGCCAAATGTTTGTAAATCACGTCTTATTTTCCTGAGGTTTTTCACTCCACCAAATCTTACAAATCATTGAAA GAAATATATTCTAACAGTACGCACTGAATAGTGAAAATAATTAGACATTTTAAGAACCAGAGCCATAGAATTATTTTAAATTAGTAGAAA AGAGGAGCTATTTCCGAATCTATAGAATAAAGTACCACCTAAAACTGAATTTTATCATATAAGCAAGTAATACCTATTAGTCATACCTAA ATTTTTCAGCACTTCATTCAATTAAAATACATGAATTTTAAATATTTTACATGATGTGAATAGGCATGATAATACTTTTAGTATAAAATC TAAACTTTTTCCATTTATCAGAAATGATAAAATCCAGTTACCACATATCACGTTTATAAAATCCTTAATTAAATGAGTAACTTCTAAAAT ATAACAATACTAAATATCACACTGCGATGGAGGTCCCAAATATGTGGTCTATCACCACTGAATTCATGTAATAGATAAGAAAAAAATTAG AGGTGGATGTCTTGTTTTGTGTCATGAATTACTAAAATCTCTTAGTAGTTGTGGTATATTTTTGAGTAAAATTACCATTTCCAGATTTGA GTTTGAAGGGCTTTTATAGTTGTATTTTCCTCCTCACTGTTAATAATCATAATCCTTTTTCAGTATTTTAGTGGCCTTGAACAACTGGTT TATCTACAATCTCAAATCCTAAGTGTATAATTATGTGCAATGTTCAATACCTCATATAATACTTGCTCAACAGTATAGTGGTACCAATGG CATTAAGATGGTGTTTTTGTTCTACATATTTTTCAATAATTTATTCTTTCTAATGTTGAAATTATATCAGGCTTTACCGGTTTTTTTAGT TGTTTAAATAAGTAATATTTTCAAAAGAATAAAATAACCAATGATATCTCTTGGAATAATCTGTAAAACGTAGTTATAAAATTCTATTTT >15044_15044_2_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000261769_TRHDE_chr12_72771775_ENST00000261180_length(amino acids)=852AA_BP=179 MAAATHPLSVASELQSTCELAEVSSDSSPLQPGPTRPHPAPALARRPRPAMGPWSRSLSALLLLLQVSSWLCQEPEPCHPGFDAESYTFT VPRRHLERGRVLGRVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVYAWDSTYRKFSTKVTLNTVGHHHRPPPHQV RLYARPDAIRRGSGDYALHITKRLIEFYEDYFKVPYSLPKLDLLAVPKHPYAAMENWGLSIFVEQRILLDPSVSSISYLLDVTMVIVHEI CHQWFGDLVTPVWWEDVWLKEGFAHYFEFVGTDYLYPGWNMEKQRFLTDVLHEVMLLDGLASSHPVSQEVLQATDIDRVFDWIAYKKGAA LIRMLANFMGHSVFQRGLQDYLTIHKYGNAARNDLWNTLSEALKRNGKYVNIQEVMDQWTLQMGYPVITILGNTTAENRIIITQQHFIYD ISAKTKALKLQNNSYLWQIPLTIVVGNRSHVSSEAIIWVSNKSEHHRITYLDKGSWLLGNINQTGYFRVNYDLRNWRLLIDQLIRNHEVL SVSNRAGLIDDAFSLARAGYLPQNIPLEIIRYLSEEKDFLPWHAASRALYPLDKLLDRMENYNIFNEYILKQVATTYIKLGWPKNNFNGS LVQASYQHEELRREVIMLACSFGNKHCHQQASTLISDWISSNRNRIPLNVRDIVYCTGVSLLDEDVWEFIWMKFHSTTAVSEKKILLEAL TCSDDRNLLNRLLNLSLNSEVVLDQDAIDVIIHVARNPHGRDLAWKFFRDKWKILNTRYGEALFMNSKLISGVTEFLNTEGELKELKNFM -------------------------------------------------------------- >15044_15044_3_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000422392_TRHDE_chr12_72771774_ENST00000261180_length(transcript)=4920nt_BP=451nt GCTCCAGCCCGGCCCGACCCGACCGCACCCGGCGCCTGCCCTCGCTCGGCGTCCCCGGCCAGCCATGGGCCCTTGGAGCCGCAGCCTCTC GGCGCTGCTGCTGCTGCTGCAGGTCTCCTCTTGGCTCTGCCAGGAGCCGGAGCCCTGCCACCCTGGCTTTGACGCCGAGAGCTACACGTT CACGGTGCCCCGGCGCCACCTGGAGAGAGGCCGCGTCCTGGGCAGAGTGAATTTTGAAGATTGCACCGGTCGACAAAGGACAGCCTATTT TTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGATTACAGTCAAAAGGCCTCTACGGTTTCATAACCCACAGATCCATTTCTT GGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCAAAGTCACGCTGAATACAGTGGGGCACCACCACCGCCCCCCGCCCCATCA GGTACGATTATATGCAAGACCTGATGCTATCAGAAGAGGATCCGGGGACTATGCTCTCCATATAACAAAGAGATTAATAGAATTTTATGA AGACTACTTTAAAGTGCCCTATTCCTTGCCAAAACTAGATCTTTTAGCTGTGCCTAAGCATCCGTATGCTGCTATGGAGAACTGGGGACT AAGTATTTTTGTGGAACAAAGAATACTGCTGGATCCCAGTGTTTCATCTATTTCTTATTTGCTGGATGTCACCATGGTCATTGTTCATGA GATATGTCACCAGTGGTTTGGTGACCTTGTGACGCCTGTGTGGTGGGAAGACGTGTGGCTGAAGGAAGGGTTTGCTCACTACTTTGAATT TGTTGGTACAGACTACCTCTATCCTGGCTGGAACATGGAAAAGCAGAGGTTTCTGACCGATGTTCTGCATGAAGTGATGCTGCTGGACGG TTTGGCCAGTTCCCATCCAGTATCACAGGAAGTGCTGCAGGCAACAGATATTGACAGGGTGTTTGACTGGATCGCATATAAAAAGGGTGC TGCTTTAATAAGAATGCTGGCTAATTTTATGGGCCATTCAGTTTTCCAGAGGGGTTTGCAAGATTATTTAACCATTCATAAGTATGGTAA TGCAGCCAGAAATGATCTCTGGAATACATTATCGGAGGCTTTAAAAAGAAATGGGAAATATGTAAATATACAAGAAGTAATGGATCAGTG GACACTCCAGATGGGTTATCCTGTTATCACCATCTTGGGAAACACAACAGCAGAAAATAGAATAATAATTACCCAACAGCATTTTATCTA TGATATCAGTGCTAAAACTAAAGCACTTAAACTTCAGAATAACAGTTACCTGTGGCAGATTCCATTAACTATTGTGGTAGGAAATAGAAG CCATGTGTCTTCAGAAGCAATTATTTGGGTGTCTAACAAATCAGAGCACCACAGAATAACTTATTTGGACAAAGGAAGCTGGCTGCTGGG GAACATCAATCAAACTGGCTATTTTAGAGTCAACTATGACCTAAGGAACTGGAGATTATTAATTGATCAATTAATCCGGAATCATGAGGT TCTTTCTGTCAGTAACCGAGCGGGCTTGATCGATGATGCCTTCAGCCTAGCCAGGGCTGGCTATTTGCCTCAGAATATTCCTCTGGAGAT TATCAGATACCTGTCTGAGGAGAAGGATTTTCTTCCTTGGCATGCTGCCAGCCGAGCTCTTTATCCTCTAGATAAATTACTGGACCGCAT GGAAAACTACAACATTTTCAATGAATATATTTTAAAGCAAGTTGCAACAACATATATCAAGCTTGGGTGGCCGAAAAATAATTTTAATGG ATCTCTTGTTCAAGCATCCTACCAACATGAAGAACTACGTAGAGAAGTTATAATGCTGGCCTGCAGTTTTGGCAACAAGCACTGTCACCA ACAGGCATCAACACTTATTTCAGATTGGATTTCCAGCAACAGGAACAGAATACCACTAAATGTTAGAGACATCGTATACTGTACAGGAGT GTCACTACTGGATGAGGATGTCTGGGAATTCATATGGATGAAATTCCATTCCACCACAGCAGTTTCTGAGAAGAAAATATTATTGGAAGC CTTAACTTGCAGTGATGACAGGAATTTATTAAACAGGCTTCTAAATCTGTCACTGAATTCTGAGGTGGTGCTGGATCAAGATGCAATTGA TGTCATAATCCATGTAGCTCGAAATCCACATGGTCGAGACCTTGCCTGGAAGTTTTTCAGGGATAAATGGAAGATATTAAATACCAGGTA TGGAGAAGCATTGTTTATGAATTCCAAACTCATCAGTGGTGTCACAGAATTTCTTAATACTGAAGGTGAACTCAAAGAGCTCAAGAACTT CATGAAAAACTATGATGGGGTAGCTGCTGCTTCTTTCTCACGAGCTGTGGAAACTGTCGAAGCCAATGTGCGCTGGAAAATGCTTTACCA AGACGAGCTTTTCCAATGGTTAGGAAAAGCTCTAAGACACTAATATATGTATCTTATAAACAAACAATTCAACTCAGAAGTTTATGAGAA GACACGCTTTTTGTGGAATGAGGAAAATGTACTACCTAGAAAATGGCCAGATTTTCAGTGTTAACGTGTGGGAGGAATTTTTTTTTTAGT TTTTATTTTTTGGTTTTGGGGGATATTTTTTATTTGTTTCATTCATTCTGTTCTGTTTCTCTACTGGGTGTTCCTCTCTAAAGAAACTCT TGCAAGTGAAACTAGCCATGATTGCTTCAGCTGTACATTCCTTGCTGTACAGGACCAAATATGATAGTGATGCATGTTGATGTTACAGTC AATTTGGAAAAACATATTCAGAATATCTGTGCATGGATATATTGTCCTGCCTGTGTTCCAGCATGCTTATTTCAAACGTCCAGTGTTGTG TGTGAATATGTGTTACACCTAGGATGGGCATTATGCAAAAGCACAAAGATTATATATGACAATCAGTATTGCAATGAAAGAAAAACTAAA AACAGAAATGATATTCTCAATTTTGGGCAATGTGAGAGGTAAAATAGCCCTTGACATGATGAACATCACTTATTTCAGCACTTGGATTGT CTGGCAATGATTACTGTGTTGCTAACTCATTTTCTTTGAGTTAAAGCTGTGTATACATTTTAAAAGGCATATAGATAGTGTATGCATATG TATATGTACATAGGGAAGCCCCATATGTATATAGTATGTTGTACACTGCACATGTACAAAGAATGTCTTCAGATCAAAGAAAATTTATCT CTTTTTATAAACTTAAGGACAGTTGCAAAAGGCTTCAAGGAATTTATCTCAACATTATTCTTTCTATGTCCTAACTAAATTTCTCAACTG TTATGAATTTTTCATCTACTTCTTGAACAGTGGTCTATTCTGCTACATGAAGATGAATACAAACAAAATTTTTGTATAAACTACTATTCC AGTTCTCCTGTGTCAGTCTTGCCTATAGATTTTGCCATCGTTTTCTGTCAAAGTTCCTTTTGCATGAAACAATTATGCAAACTTATAATT ATTAGTGCTGAAAAAGAGTTTATTTTCCATCTTGTTTGTTTTCCTACCTTATGCTGAGTAGTCCAGAGAGTTAAAAAAATTCTCTGCATG TTGGTCTTTTAAGTCTGTTTTGCTCTAATCCTCCATTAAGCGAGCATACCTCAAGTGGGTCTATTAGCATTTAATGACCTTTTGTGCCAG TTGTGCCATCCCTTAAGATGAAAAGTTCCTTTTCTTGTGTTAATGTACAAAGCTTTTCTTTTGGCACTGACAACTGTGTTCTACCTGGGA ATTTTGAATAGCCATTTTCATGGCTGTGTGTTGTGTAACACAAATGTTTTTAAATGGTATTCTCACCCAGTAGGCCAGCTCTCCAAACGT TGCTTAGATGCTTCAAAATTAGCATATTTTAAGTTTACCAGTATAAAATACCAATGCAACTACTCTACATAGCCAAATGTTTGTAAATCA CGTCTTATTTTCCTGAGGTTTTTCACTCCACCAAATCTTACAAATCATTGAAAGAAATATATTCTAACAGTACGCACTGAATAGTGAAAA TAATTAGACATTTTAAGAACCAGAGCCATAGAATTATTTTAAATTAGTAGAAAAGAGGAGCTATTTCCGAATCTATAGAATAAAGTACCA CCTAAAACTGAATTTTATCATATAAGCAAGTAATACCTATTAGTCATACCTAAATTTTTCAGCACTTCATTCAATTAAAATACATGAATT TTAAATATTTTACATGATGTGAATAGGCATGATAATACTTTTAGTATAAAATCTAAACTTTTTCCATTTATCAGAAATGATAAAATCCAG TTACCACATATCACGTTTATAAAATCCTTAATTAAATGAGTAACTTCTAAAATATAACAATACTAAATATCACACTGCGATGGAGGTCCC AAATATGTGGTCTATCACCACTGAATTCATGTAATAGATAAGAAAAAAATTAGAGGTGGATGTCTTGTTTTGTGTCATGAATTACTAAAA TCTCTTAGTAGTTGTGGTATATTTTTGAGTAAAATTACCATTTCCAGATTTGAGTTTGAAGGGCTTTTATAGTTGTATTTTCCTCCTCAC TGTTAATAATCATAATCCTTTTTCAGTATTTTAGTGGCCTTGAACAACTGGTTTATCTACAATCTCAAATCCTAAGTGTATAATTATGTG CAATGTTCAATACCTCATATAATACTTGCTCAACAGTATAGTGGTACCAATGGCATTAAGATGGTGTTTTTGTTCTACATATTTTTCAAT AATTTATTCTTTCTAATGTTGAAATTATATCAGGCTTTACCGGTTTTTTTAGTTGTTTAAATAAGTAATATTTTCAAAAGAATAAAATAA >15044_15044_3_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000422392_TRHDE_chr12_72771774_ENST00000261180_length(amino acids)=802AA_BP=129 MGPWSRSLSALLLLLQVSSWLCQEPEPCHPGFDAESYTFTVPRRHLERGRVLGRVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLR FHNPQIHFLVYAWDSTYRKFSTKVTLNTVGHHHRPPPHQVRLYARPDAIRRGSGDYALHITKRLIEFYEDYFKVPYSLPKLDLLAVPKHP YAAMENWGLSIFVEQRILLDPSVSSISYLLDVTMVIVHEICHQWFGDLVTPVWWEDVWLKEGFAHYFEFVGTDYLYPGWNMEKQRFLTDV LHEVMLLDGLASSHPVSQEVLQATDIDRVFDWIAYKKGAALIRMLANFMGHSVFQRGLQDYLTIHKYGNAARNDLWNTLSEALKRNGKYV NIQEVMDQWTLQMGYPVITILGNTTAENRIIITQQHFIYDISAKTKALKLQNNSYLWQIPLTIVVGNRSHVSSEAIIWVSNKSEHHRITY LDKGSWLLGNINQTGYFRVNYDLRNWRLLIDQLIRNHEVLSVSNRAGLIDDAFSLARAGYLPQNIPLEIIRYLSEEKDFLPWHAASRALY PLDKLLDRMENYNIFNEYILKQVATTYIKLGWPKNNFNGSLVQASYQHEELRREVIMLACSFGNKHCHQQASTLISDWISSNRNRIPLNV RDIVYCTGVSLLDEDVWEFIWMKFHSTTAVSEKKILLEALTCSDDRNLLNRLLNLSLNSEVVLDQDAIDVIIHVARNPHGRDLAWKFFRD -------------------------------------------------------------- >15044_15044_4_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000422392_TRHDE_chr12_72771775_ENST00000261180_length(transcript)=4920nt_BP=451nt GCTCCAGCCCGGCCCGACCCGACCGCACCCGGCGCCTGCCCTCGCTCGGCGTCCCCGGCCAGCCATGGGCCCTTGGAGCCGCAGCCTCTC GGCGCTGCTGCTGCTGCTGCAGGTCTCCTCTTGGCTCTGCCAGGAGCCGGAGCCCTGCCACCCTGGCTTTGACGCCGAGAGCTACACGTT CACGGTGCCCCGGCGCCACCTGGAGAGAGGCCGCGTCCTGGGCAGAGTGAATTTTGAAGATTGCACCGGTCGACAAAGGACAGCCTATTT TTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGATTACAGTCAAAAGGCCTCTACGGTTTCATAACCCACAGATCCATTTCTT GGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCAAAGTCACGCTGAATACAGTGGGGCACCACCACCGCCCCCCGCCCCATCA GGTACGATTATATGCAAGACCTGATGCTATCAGAAGAGGATCCGGGGACTATGCTCTCCATATAACAAAGAGATTAATAGAATTTTATGA AGACTACTTTAAAGTGCCCTATTCCTTGCCAAAACTAGATCTTTTAGCTGTGCCTAAGCATCCGTATGCTGCTATGGAGAACTGGGGACT AAGTATTTTTGTGGAACAAAGAATACTGCTGGATCCCAGTGTTTCATCTATTTCTTATTTGCTGGATGTCACCATGGTCATTGTTCATGA GATATGTCACCAGTGGTTTGGTGACCTTGTGACGCCTGTGTGGTGGGAAGACGTGTGGCTGAAGGAAGGGTTTGCTCACTACTTTGAATT TGTTGGTACAGACTACCTCTATCCTGGCTGGAACATGGAAAAGCAGAGGTTTCTGACCGATGTTCTGCATGAAGTGATGCTGCTGGACGG TTTGGCCAGTTCCCATCCAGTATCACAGGAAGTGCTGCAGGCAACAGATATTGACAGGGTGTTTGACTGGATCGCATATAAAAAGGGTGC TGCTTTAATAAGAATGCTGGCTAATTTTATGGGCCATTCAGTTTTCCAGAGGGGTTTGCAAGATTATTTAACCATTCATAAGTATGGTAA TGCAGCCAGAAATGATCTCTGGAATACATTATCGGAGGCTTTAAAAAGAAATGGGAAATATGTAAATATACAAGAAGTAATGGATCAGTG GACACTCCAGATGGGTTATCCTGTTATCACCATCTTGGGAAACACAACAGCAGAAAATAGAATAATAATTACCCAACAGCATTTTATCTA TGATATCAGTGCTAAAACTAAAGCACTTAAACTTCAGAATAACAGTTACCTGTGGCAGATTCCATTAACTATTGTGGTAGGAAATAGAAG CCATGTGTCTTCAGAAGCAATTATTTGGGTGTCTAACAAATCAGAGCACCACAGAATAACTTATTTGGACAAAGGAAGCTGGCTGCTGGG GAACATCAATCAAACTGGCTATTTTAGAGTCAACTATGACCTAAGGAACTGGAGATTATTAATTGATCAATTAATCCGGAATCATGAGGT TCTTTCTGTCAGTAACCGAGCGGGCTTGATCGATGATGCCTTCAGCCTAGCCAGGGCTGGCTATTTGCCTCAGAATATTCCTCTGGAGAT TATCAGATACCTGTCTGAGGAGAAGGATTTTCTTCCTTGGCATGCTGCCAGCCGAGCTCTTTATCCTCTAGATAAATTACTGGACCGCAT GGAAAACTACAACATTTTCAATGAATATATTTTAAAGCAAGTTGCAACAACATATATCAAGCTTGGGTGGCCGAAAAATAATTTTAATGG ATCTCTTGTTCAAGCATCCTACCAACATGAAGAACTACGTAGAGAAGTTATAATGCTGGCCTGCAGTTTTGGCAACAAGCACTGTCACCA ACAGGCATCAACACTTATTTCAGATTGGATTTCCAGCAACAGGAACAGAATACCACTAAATGTTAGAGACATCGTATACTGTACAGGAGT GTCACTACTGGATGAGGATGTCTGGGAATTCATATGGATGAAATTCCATTCCACCACAGCAGTTTCTGAGAAGAAAATATTATTGGAAGC CTTAACTTGCAGTGATGACAGGAATTTATTAAACAGGCTTCTAAATCTGTCACTGAATTCTGAGGTGGTGCTGGATCAAGATGCAATTGA TGTCATAATCCATGTAGCTCGAAATCCACATGGTCGAGACCTTGCCTGGAAGTTTTTCAGGGATAAATGGAAGATATTAAATACCAGGTA TGGAGAAGCATTGTTTATGAATTCCAAACTCATCAGTGGTGTCACAGAATTTCTTAATACTGAAGGTGAACTCAAAGAGCTCAAGAACTT CATGAAAAACTATGATGGGGTAGCTGCTGCTTCTTTCTCACGAGCTGTGGAAACTGTCGAAGCCAATGTGCGCTGGAAAATGCTTTACCA AGACGAGCTTTTCCAATGGTTAGGAAAAGCTCTAAGACACTAATATATGTATCTTATAAACAAACAATTCAACTCAGAAGTTTATGAGAA GACACGCTTTTTGTGGAATGAGGAAAATGTACTACCTAGAAAATGGCCAGATTTTCAGTGTTAACGTGTGGGAGGAATTTTTTTTTTAGT TTTTATTTTTTGGTTTTGGGGGATATTTTTTATTTGTTTCATTCATTCTGTTCTGTTTCTCTACTGGGTGTTCCTCTCTAAAGAAACTCT TGCAAGTGAAACTAGCCATGATTGCTTCAGCTGTACATTCCTTGCTGTACAGGACCAAATATGATAGTGATGCATGTTGATGTTACAGTC AATTTGGAAAAACATATTCAGAATATCTGTGCATGGATATATTGTCCTGCCTGTGTTCCAGCATGCTTATTTCAAACGTCCAGTGTTGTG TGTGAATATGTGTTACACCTAGGATGGGCATTATGCAAAAGCACAAAGATTATATATGACAATCAGTATTGCAATGAAAGAAAAACTAAA AACAGAAATGATATTCTCAATTTTGGGCAATGTGAGAGGTAAAATAGCCCTTGACATGATGAACATCACTTATTTCAGCACTTGGATTGT CTGGCAATGATTACTGTGTTGCTAACTCATTTTCTTTGAGTTAAAGCTGTGTATACATTTTAAAAGGCATATAGATAGTGTATGCATATG TATATGTACATAGGGAAGCCCCATATGTATATAGTATGTTGTACACTGCACATGTACAAAGAATGTCTTCAGATCAAAGAAAATTTATCT CTTTTTATAAACTTAAGGACAGTTGCAAAAGGCTTCAAGGAATTTATCTCAACATTATTCTTTCTATGTCCTAACTAAATTTCTCAACTG TTATGAATTTTTCATCTACTTCTTGAACAGTGGTCTATTCTGCTACATGAAGATGAATACAAACAAAATTTTTGTATAAACTACTATTCC AGTTCTCCTGTGTCAGTCTTGCCTATAGATTTTGCCATCGTTTTCTGTCAAAGTTCCTTTTGCATGAAACAATTATGCAAACTTATAATT ATTAGTGCTGAAAAAGAGTTTATTTTCCATCTTGTTTGTTTTCCTACCTTATGCTGAGTAGTCCAGAGAGTTAAAAAAATTCTCTGCATG TTGGTCTTTTAAGTCTGTTTTGCTCTAATCCTCCATTAAGCGAGCATACCTCAAGTGGGTCTATTAGCATTTAATGACCTTTTGTGCCAG TTGTGCCATCCCTTAAGATGAAAAGTTCCTTTTCTTGTGTTAATGTACAAAGCTTTTCTTTTGGCACTGACAACTGTGTTCTACCTGGGA ATTTTGAATAGCCATTTTCATGGCTGTGTGTTGTGTAACACAAATGTTTTTAAATGGTATTCTCACCCAGTAGGCCAGCTCTCCAAACGT TGCTTAGATGCTTCAAAATTAGCATATTTTAAGTTTACCAGTATAAAATACCAATGCAACTACTCTACATAGCCAAATGTTTGTAAATCA CGTCTTATTTTCCTGAGGTTTTTCACTCCACCAAATCTTACAAATCATTGAAAGAAATATATTCTAACAGTACGCACTGAATAGTGAAAA TAATTAGACATTTTAAGAACCAGAGCCATAGAATTATTTTAAATTAGTAGAAAAGAGGAGCTATTTCCGAATCTATAGAATAAAGTACCA CCTAAAACTGAATTTTATCATATAAGCAAGTAATACCTATTAGTCATACCTAAATTTTTCAGCACTTCATTCAATTAAAATACATGAATT TTAAATATTTTACATGATGTGAATAGGCATGATAATACTTTTAGTATAAAATCTAAACTTTTTCCATTTATCAGAAATGATAAAATCCAG TTACCACATATCACGTTTATAAAATCCTTAATTAAATGAGTAACTTCTAAAATATAACAATACTAAATATCACACTGCGATGGAGGTCCC AAATATGTGGTCTATCACCACTGAATTCATGTAATAGATAAGAAAAAAATTAGAGGTGGATGTCTTGTTTTGTGTCATGAATTACTAAAA TCTCTTAGTAGTTGTGGTATATTTTTGAGTAAAATTACCATTTCCAGATTTGAGTTTGAAGGGCTTTTATAGTTGTATTTTCCTCCTCAC TGTTAATAATCATAATCCTTTTTCAGTATTTTAGTGGCCTTGAACAACTGGTTTATCTACAATCTCAAATCCTAAGTGTATAATTATGTG CAATGTTCAATACCTCATATAATACTTGCTCAACAGTATAGTGGTACCAATGGCATTAAGATGGTGTTTTTGTTCTACATATTTTTCAAT AATTTATTCTTTCTAATGTTGAAATTATATCAGGCTTTACCGGTTTTTTTAGTTGTTTAAATAAGTAATATTTTCAAAAGAATAAAATAA >15044_15044_4_CDH1-TRHDE_CDH1_chr16_68835796_ENST00000422392_TRHDE_chr12_72771775_ENST00000261180_length(amino acids)=802AA_BP=129 MGPWSRSLSALLLLLQVSSWLCQEPEPCHPGFDAESYTFTVPRRHLERGRVLGRVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLR FHNPQIHFLVYAWDSTYRKFSTKVTLNTVGHHHRPPPHQVRLYARPDAIRRGSGDYALHITKRLIEFYEDYFKVPYSLPKLDLLAVPKHP YAAMENWGLSIFVEQRILLDPSVSSISYLLDVTMVIVHEICHQWFGDLVTPVWWEDVWLKEGFAHYFEFVGTDYLYPGWNMEKQRFLTDV LHEVMLLDGLASSHPVSQEVLQATDIDRVFDWIAYKKGAALIRMLANFMGHSVFQRGLQDYLTIHKYGNAARNDLWNTLSEALKRNGKYV NIQEVMDQWTLQMGYPVITILGNTTAENRIIITQQHFIYDISAKTKALKLQNNSYLWQIPLTIVVGNRSHVSSEAIIWVSNKSEHHRITY LDKGSWLLGNINQTGYFRVNYDLRNWRLLIDQLIRNHEVLSVSNRAGLIDDAFSLARAGYLPQNIPLEIIRYLSEEKDFLPWHAASRALY PLDKLLDRMENYNIFNEYILKQVATTYIKLGWPKNNFNGSLVQASYQHEELRREVIMLACSFGNKHCHQQASTLISDWISSNRNRIPLNV RDIVYCTGVSLLDEDVWEFIWMKFHSTTAVSEKKILLEALTCSDDRNLLNRLLNLSLNSEVVLDQDAIDVIIHVARNPHGRDLAWKFFRD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CDH1-TRHDE |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CDH1-TRHDE |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CDH1-TRHDE |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CDH1 | C1708349 | Hereditary Diffuse Gastric Cancer | 15 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | CDH1 | C0346153 | Breast Cancer, Familial | 12 | CLINGEN |
Hgene | CDH1 | C0009405 | Hereditary Nonpolyposis Colorectal Neoplasms | 6 | CLINGEN |
Hgene | CDH1 | C0024623 | Malignant neoplasm of stomach | 6 | CGI;CTD_human;UNIPROT |
Hgene | CDH1 | C0038356 | Stomach Neoplasms | 6 | CGI;CTD_human |
Hgene | CDH1 | C1112155 | Hereditary non-polyposis colorectal cancer syndrome | 6 | CLINGEN |
Hgene | CDH1 | C1333990 | Hereditary Nonpolyposis Colorectal Cancer | 6 | CLINGEN |
Hgene | CDH1 | C1333991 | Hereditary Non-Polyposis Colon Cancer Type 2 | 6 | CLINGEN |
Hgene | CDH1 | C2936783 | Colorectal cancer, hereditary nonpolyposis, type 1 | 6 | CLINGEN |
Hgene | CDH1 | C0006142 | Malignant neoplasm of breast | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | CDH1 | C0033578 | Prostatic Neoplasms | 4 | CTD_human |
Hgene | CDH1 | C0376358 | Malignant neoplasm of prostate | 4 | CTD_human;GENOMICS_ENGLAND |
Hgene | CDH1 | C0678222 | Breast Carcinoma | 4 | CTD_human |
Hgene | CDH1 | C1257931 | Mammary Neoplasms, Human | 4 | CTD_human |
Hgene | CDH1 | C1458155 | Mammary Neoplasms | 4 | CTD_human |
Hgene | CDH1 | C4704874 | Mammary Carcinoma, Human | 4 | CTD_human |
Hgene | CDH1 | C0007097 | Carcinoma | 3 | CTD_human |
Hgene | CDH1 | C0205696 | Anaplastic carcinoma | 3 | CTD_human |
Hgene | CDH1 | C0205697 | Carcinoma, Spindle-Cell | 3 | CTD_human |
Hgene | CDH1 | C0205698 | Undifferentiated carcinoma | 3 | CTD_human |
Hgene | CDH1 | C0205699 | Carcinomatosis | 3 | CTD_human |
Hgene | CDH1 | C0005684 | Malignant neoplasm of urinary bladder | 2 | CTD_human |
Hgene | CDH1 | C0005695 | Bladder Neoplasm | 2 | CTD_human |
Hgene | CDH1 | C0009402 | Colorectal Carcinoma | 2 | CTD_human |
Hgene | CDH1 | C0009404 | Colorectal Neoplasms | 2 | CTD_human |
Hgene | CDH1 | C0019207 | Hepatoma, Morris | 2 | CTD_human |
Hgene | CDH1 | C0019208 | Hepatoma, Novikoff | 2 | CTD_human |
Hgene | CDH1 | C0021367 | Mammary Ductal Carcinoma | 2 | CTD_human |
Hgene | CDH1 | C0023904 | Liver Neoplasms, Experimental | 2 | CTD_human |
Hgene | CDH1 | C0027626 | Neoplasm Invasiveness | 2 | CTD_human |
Hgene | CDH1 | C0027627 | Neoplasm Metastasis | 2 | CTD_human |
Hgene | CDH1 | C0086404 | Experimental Hepatoma | 2 | CTD_human |
Hgene | CDH1 | C0206692 | Carcinoma, Lobular | 2 | CGI;CTD_human;UNIPROT |
Hgene | CDH1 | C1134719 | Invasive Ductal Breast Carcinoma | 2 | CTD_human |
Hgene | CDH1 | C2931456 | Prostate cancer, familial | 2 | CTD_human |
Hgene | CDH1 | C4551988 | BLEPHAROCHEILODONTIC SYNDROME 1 | 2 | GENOMICS_ENGLAND;UNIPROT |
Hgene | CDH1 | C4722327 | PROSTATE CANCER, HEREDITARY, 1 | 2 | CTD_human |
Hgene | CDH1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | CDH1 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Hgene | CDH1 | C0009324 | Ulcerative Colitis | 1 | CTD_human |
Hgene | CDH1 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Hgene | CDH1 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
Hgene | CDH1 | C0014476 | Eperythrozoonosis | 1 | CTD_human |
Hgene | CDH1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | CDH1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | CDH1 | C0025500 | Mesothelioma | 1 | CTD_human |
Hgene | CDH1 | C0026936 | Mycoplasma Infections | 1 | CTD_human |
Hgene | CDH1 | C0027645 | Neoplasm Seeding | 1 | CTD_human |
Hgene | CDH1 | C0027659 | Neoplasms, Experimental | 1 | CTD_human |
Hgene | CDH1 | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | CDH1 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Hgene | CDH1 | C0032927 | Precancerous Conditions | 1 | CTD_human |
Hgene | CDH1 | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
Hgene | CDH1 | C0079487 | Helicobacter Infections | 1 | CTD_human |
Hgene | CDH1 | C0158646 | Cleft palate with cleft lip | 1 | ORPHANET |
Hgene | CDH1 | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |
Hgene | CDH1 | C0235874 | Disease Exacerbation | 1 | CTD_human |
Hgene | CDH1 | C0282313 | Condition, Preneoplastic | 1 | CTD_human |
Hgene | CDH1 | C0282612 | Prostatic Intraepithelial Neoplasias | 1 | CTD_human |
Hgene | CDH1 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
Hgene | CDH1 | C0476089 | Endometrial Carcinoma | 1 | CTD_human;GENOMICS_ENGLAND |
Hgene | CDH1 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | CDH1 | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | CDH1 | C1176475 | Ductal Carcinoma | 1 | CTD_human |
Hgene | CDH1 | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
Hgene | CDH1 | C1861536 | Blepharo-cheilo-dontic syndrome | 1 | ORPHANET |